This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5mg | $135 | To Be Confirmed |
10mg | $220 | To Be Confirmed |
25mg | $340 | To Be Confirmed |
50mg | $510 | To Be Confirmed |
100mg | $769 | To Be Confirmed |
250mg | $1340 | To Be Confirmed |
500mg | $1950 | To Be Confirmed |
Cat #: V3362 CAS #: 83002-04-4 Purity ≥ 98%
Description: CP-55940 (CP-55,940; CP55,940) is a novel, potent and non-selective cannabinoid receptor agonist with Ki values of 0.58 and 0.69 nM for human recombinant CB1 and CB2, respectively. It is a cannabinoid which mimics the effects of naturally occurring THC (one of the psychoactive compounds found in cannabis). CP 55,940 was created by Pfizer in 1974 but was never marketed. It is currently used to study the endocannabinoid system. Displays high and roughly equal affinity for both central and peripheral cannabinoid receptors (Ki = 0.6 - 5.0 and 0.7 - 2.6 nM at CB1 and CB2 respectively; EC50 values are 0.2, 0.3 and 5 nM at CB1, CB2 and GRP55 respectively).
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
CAS No. | 83002-04-4 |
---|---|
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.